Cullinan Therapeutics
Tracked across 2 events · 13 articles · First seen May 26, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Cullinan Therapeutics is hosting an Immunology Day to present new clinical data for its autoimmune disease therapies, CLN-978 and velinotamig, which could significantly impact its stock price and future development.
May 26, 2026 · 7 articles
Tech
Cullinan Therapeutics announced that it will host a virtual event for analysts and institutional investors on September 14, 2026, at 8:00 a.m. ET to discuss results from the planned interim analysis of the Phase 3…
Impact: Cullinan Therapeutics is the central company hosting the investor event and sponsor of the REZILIENT3 trial; positive data could boost its valuation and pipeline credibility.
Sep 10, 2026 · 6 articles
50
Cullinan Therapeutics announced virtual investor eventCullinan REZILIENT3...
ERGEN INTELLIGENCE
Track Cullinan Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard